Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1333465.RAUEfEh0koA3cpmHT_oBDGW-vleaFbeX_uKav--mdtLU4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1333465.RAUEfEh0koA3cpmHT_oBDGW-vleaFbeX_uKav--mdtLU4130_assertion type Assertion NP1333465.RAUEfEh0koA3cpmHT_oBDGW-vleaFbeX_uKav--mdtLU4130_head.
- NP1333465.RAUEfEh0koA3cpmHT_oBDGW-vleaFbeX_uKav--mdtLU4130_assertion wasGeneratedBy ECO_0000203 NP1333465.RAUEfEh0koA3cpmHT_oBDGW-vleaFbeX_uKav--mdtLU4130_provenance.
- NP1333465.RAUEfEh0koA3cpmHT_oBDGW-vleaFbeX_uKav--mdtLU4130_assertion wasDerivedFrom befree-2016 NP1333465.RAUEfEh0koA3cpmHT_oBDGW-vleaFbeX_uKav--mdtLU4130_provenance.
- NP1333465.RAUEfEh0koA3cpmHT_oBDGW-vleaFbeX_uKav--mdtLU4130_assertion SIO_000772 8128981 NP1333465.RAUEfEh0koA3cpmHT_oBDGW-vleaFbeX_uKav--mdtLU4130_provenance.
- NP1333465.RAUEfEh0koA3cpmHT_oBDGW-vleaFbeX_uKav--mdtLU4130_assertion evidence source_evidence_literature NP1333465.RAUEfEh0koA3cpmHT_oBDGW-vleaFbeX_uKav--mdtLU4130_provenance.
- NP1333465.RAUEfEh0koA3cpmHT_oBDGW-vleaFbeX_uKav--mdtLU4130_assertion description "[Two major types can be distinguished based on electrophysiologic phenotypes: CMT type 1 (CMT1) displays uniformly decreased nerve conduction velocity associated with a demyelinating hypertrophic neuropathy, and CMT type 2 (CMT2) displays normal or near-normal nerve conduction velocity associated with a neuronal defect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1333465.RAUEfEh0koA3cpmHT_oBDGW-vleaFbeX_uKav--mdtLU4130_provenance.